Your browser doesn't support javascript.
loading
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
Lu, Liang-He; Zhang, Yong-Fa; Mu-Yan, Cai; Kan, Anna; Zhong, Xiao-Ping; Mei, Jie; Ling, Yi-Hong; Li, Shao-Hua; Shi, Ming; Wei, Wei; Guo, Rong-Ping.
Afiliação
  • Lu LH; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang YF; Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Mu-Yan C; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Pathology of Sun Yat-sen University Cancer Center, China.
  • Kan A; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhong XP; Department of Surgery, Second Affiliated Hospital Shantou University Medical College, Guangdong Province, China.
  • Mei J; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Ling YH; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Pathology of Sun Yat-sen University Cancer Center, China.
  • Li SH; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Shi M; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wei W; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address: weiwei@sysucc.org.cn.
  • Guo RP; Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, China; State Key Laboratory of Oncology in South China, China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address: guorp@sysucc.org.cn.
Dig Liver Dis ; 51(10): 1430-1437, 2019 10.
Article em En | MEDLINE | ID: mdl-31054962

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bilirrubina / Plaquetas / Albumina Sérica / Falência Hepática / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bilirrubina / Plaquetas / Albumina Sérica / Falência Hepática / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China